塞马鲁肽用于治疗对二甲双胍无应答的抗精神病药物相关体重增加患者--病例系列》的更正。

IF 3.4 3区医学 Q2 PHARMACOLOGY & PHARMACY

Therapeutic Advances in Psychopharmacology Pub Date : 2024-05-28 eCollection Date: 2024-01-01 DOI:10.1177/20451253241258536

引用次数: 0

摘要

[This corrects the article DOI: 10.1177/20451253231165169.].

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Corrigendum to "Semaglutide for the treatment of antipsychotic-associated weight gain in patients not responding to metformin - a case series".

[This corrects the article DOI: 10.1177/20451253231165169.].

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Therapeutic Advances in Psychopharmacology Multiple-

CiteScore

7.90

自引率

2.40%

发文量

审稿时长

10 weeks

期刊介绍： Therapeutic Advances in Psychopharmacology delivers the highest quality peer-reviewed articles, reviews, and scholarly comment on pioneering efforts and innovative studies across all areas of psychopharmacology. The journal has a strong clinical and pharmacological focus and is aimed at clinicians and researchers in psychopharmacology, providing a forum in print and online for publishing the highest quality articles in this area.